Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Other Non-Current Assets (2018 - 2025)

Arcturus Therapeutics Holdings (ARCT) has disclosed Other Non-Current Assets for 8 consecutive years, with $1.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Assets changed 0.0% year-over-year to $1.9 million, compared with a TTM value of $1.9 million through Dec 2025, changed 0.0%, and an annual FY2025 reading of $1.9 million, changed 0.0% over the prior year.
  • Other Non-Current Assets was $1.9 million for Q4 2025 at Arcturus Therapeutics Holdings, roughly flat from $1.9 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $55.0 million in Q1 2024 and bottomed at $107000.0 in Q1 2021.
  • Average Other Non-Current Assets over 5 years is $6.1 million, with a median of $2.1 million recorded in 2021.
  • Peak annual rise in Other Non-Current Assets hit 2499.24% in 2024, while the deepest fall reached 91.48% in 2024.
  • Year by year, Other Non-Current Assets stood at $2.1 million in 2021, then rose by 0.82% to $2.1 million in 2022, then dropped by 9.98% to $1.9 million in 2023, then changed by 0.0% to $1.9 million in 2024, then changed by 0.0% to $1.9 million in 2025.
  • Business Quant data shows Other Non-Current Assets for ARCT at $1.9 million in Q4 2025, $1.9 million in Q4 2024, and $1.9 million in Q3 2024.